Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction

Steg, 2012, ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 Ito, 2006, No-reflow phenomenon and prognosis in patients with acute myocardial infarction, Nat Clin Pract Cardiovasc Med, 3, 499, 10.1038/ncpcardio0632 Piana, 1994, Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention, Circulation, 89, 2514, 10.1161/01.CIR.89.6.2514 Taniyama, 1997, Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction, J Am Coll Cardiol, 30, 1193, 10.1016/S0735-1097(97)00277-5 Burzotta, 2008, Thrombus-aspiration: a victory in the war against no reflow, Lancet, 371, 1889, 10.1016/S0140-6736(08)60808-9 Svilaas, 2008, Thrombus aspiration during primary percutaneous coronary intervention, N Engl J Med, 358, 557, 10.1056/NEJMoa0706416 De Luca, 2005, Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials, JAMA, 293, 1759, 10.1001/jama.293.14.1759 Niccoli, 2009, Myocardial no-reflow in humans, J Am Coll Cardiol, 54, 281, 10.1016/j.jacc.2009.03.054 Forman, 2006, Role of adenosine as adjunctive therapy in acute myocardial infarction, Cardiovasc Drug Rev, 24, 116, 10.1111/j.1527-3466.2006.00116.x Headrick, 2009, Adenosine receptors and reperfusion injury of the heart, Handb Exp Pharmacol, 193, 189, 10.1007/978-3-540-89615-9_7 Bates, 1991, Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required, Biochem Pharmacol, 42, S157, 10.1016/0006-2952(91)90406-U Micari, 2005, Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting, Am J Cardiol, 96, 1410, 10.1016/j.amjcard.2005.06.090 Marzilli, 2000, Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction, Circulation, 101, 2154, 10.1161/01.CIR.101.18.2154 Claeys, 2004, Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction, Am J Cardiol, 94, 9, 10.1016/j.amjcard.2004.03.021 Stoel, 2008, High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study, Catheter Cardiovasc Interv, 71, 283, 10.1002/ccd.21334 Grygier, 2011, New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention, Am J Cardiol, 107, 1131, 10.1016/j.amjcard.2010.12.010 Fokkema, 2009, Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial, Circ Cardiovasc Interv, 2, 323, 10.1161/CIRCINTERVENTIONS.109.858977.109.858977 Desmet, 2011, High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction, Eur Heart J, 32, 867, 10.1093/eurheartj/ehq492 Wang, 2004, Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction, Catheter Cardiovasc Interv, 63, 171, 10.1002/ccd.20149 Pasceri, 2005, Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction, Am J Cardiol, 95, 1358, 10.1016/j.amjcard.2005.01.082 Amit, 2006, Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial, Am Heart J, 152, 887.e9, 10.1016/j.ahj.2006.05.010 Niccoli, 2009, Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol, J Cardiovasc Med, 10, 585, 10.2459/JCM.0b013e32832b3571 Sorajja, 2005, Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction, Eur Heart J, 26, 667, 10.1093/eurheartj/ehi167 Burzotta, 2005, Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial, J Am Coll Cardiol, 46, 371, 10.1016/j.jacc.2005.04.057 Cohen, 2008, Adenosine: trigger and mediator of cardioprotection, Basic Res Cardiol, 103, 203, 10.1007/s00395-007-0687-7 Haskó, 2008, Adenosine receptors: therapeutic aspects for inflammatory and immune disease, Nat Rev Drug Discov, 7, 759, 10.1038/nrd2638 Mustafa, 2009, Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology, Handb Exp Pharmacol, 193, 161, 10.1007/978-3-540-89615-9_6 Zhao, 1996, Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium, Am J Physiol, 271, H1456 Söderbäck, 1991, Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry, Clin Sci, 81, 691, 10.1042/cs0810691 Headrick, 2005, A3 adenosine receptor-mediated protection of the ischemic heart, Vascul Pharmacol, 42, 271, 10.1016/j.vph.2005.02.009 Adair, 2005, Growth regulation of the vascular system: an emerging role for adenosine, Am J Physiol Regul Integr Comp Physiol, 289, R283, 10.1152/ajpregu.00840.2004 Toufektsian, 2006, Stimulation of A2A-adenosine receptors after myocardial infarction suppresses inflammatory activation and attenuates contractile dysfunction in the remote left ventricle, Am J Physiol Heart Circ Physiol, 290, H1410, 10.1152/ajpheart.00860.2005 Angeja, 2002, TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging, Circulation, 105, 282, 10.1161/hc0302.103588 Mahaffey, 1999, Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial, J Am Coll Cardiol, 34, 1711, 10.1016/S0735-1097(99)00418-0 Ross, 2005, A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II), J Am Coll Cardiol, 45, 1775, 10.1016/j.jacc.2005.02.061 Kloner, 2006, Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD II trial, Eur Heart J, 27, 2400, 10.1093/eurheartj/ehl094 Anfossi, 2001, Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content, Thromb Res, 102, 319, 10.1016/S0049-3848(01)00240-7 Kim, 2008, Correlation of serial cardiac magnetic resonance imaging parameters with early resolution of ST-segment elevation after primary percutaneous coronary intervention, Circ J, 72, 1621, 10.1253/circj.CJ-08-0232 Nijveldt, 2008, Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury, J Am Coll Cardiol, 52, 181, 10.1016/j.jacc.2008.04.006 Sianos, 2010, Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention, J Invasive Cardiol, 22, 6B Montalescot, 2001, Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction, N Engl J Med, 344, 1895, 10.1056/NEJM200106213442503